Colinz Laboratories Limited Reports Unaudited Earnings Results for Fourth Quarter and Audited Earnings Results for Full Year Ended Mar. 31, 2017
May 26, 2017 at 03:34 pm IST
Share
Colinz Laboratories Limited reported unaudited earnings results for fourth quarter and audited earnings results for full year ended Mar. 31, 2017. For the quarter, the company reported net sales of INR 17.437 million, profit from operations before other income and finance costs and exceptional items of INR 0.299 million, profit from ordinary activities before tax of INR 0.25 million, net profit of INR 0.191 million compared to the net sales of INR 18.368 million, profit from operations before other income and finance costs and exceptional items of INR 0.326 million, profit from ordinary activities before tax of INR 0.332 million, net profit of INR 0.154 million for the same quarter a year ago.
For the year, the company reported net sales of INR 76.366 million, profit from operations before other income and finance costs and exceptional items of INR 1.443 million, profit from ordinary activities before tax of INR 1.673 million, net profit of INR 1.809 million or INR 0.4 per basic and diluted share before and after extraordinary items compared to the net sales of INR 80.953 million, profit from operations before other income and finance costs and exceptional items of INR 1.692 million, profit from ordinary activities before tax of INR 1.514 million, net profit of INR 0.946 million or INR 0.21 per basic and diluted share before and after extraordinary items for the previous year.
Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company is engaged in the manufacturing and marketing various allopathic and ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. It provides physicians with products in the treatment of hypertension, cholesterol, diabetes, piles, pyrexia and malaria. It provides gynecologists with specialized products in the treatments of morning sickness, infertility, intrauterine growth restriction (IUGR) and maintenance of pregnancy. It also offers other products, such as hematinic, antispasmodics, anti-inflammatory/anti-allergic tablets, capsules gel and medicated shampoo. The Company markets its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh and West Bengal through its own marketing staff.